Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00177567
Status:
COMPLETED
Last Update Posted:
2005-09-15
First Post:
2005-09-13
Brief Title:
Treatment of Geriatric Bipolar Mood Disorders A Pilot Study
Sponsor:
University of Pittsburgh
Organization:
University of Pittsburgh
Study Overview
Official Title:
Treatment of Geriatric Bipolar Mood Disorders A Pilot Study
Status:
COMPLETED
Status Verified Date:
2005-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to collect pilot data on the feasibility of recruiting eliciting informed consent assessing treating and following patients aged 60 and older with bipolar mood disorders
Detailed Description:
Study specific aims are
to establish a recruitment referral and collaborative network for elderly bipolar patients in collaboration with the NIMH funded STEP-BD
to establish an outpatient treatment clinic at the Bellefield Towers site of the NIMH funded Intervention Research Center for Late Life Mood Disorders
to implement standardized care pathways compatible with STEP-BD treatment algorithms for mood stabilizing pharmacotherapy
to document short- and long-term treatment response with respect to affective symptoms sleep general life functioning cognition treatment-emergent side effects
to establish the clinical infrastructure necessary for randomized controlled clinical trials and for clinical research training in bipolar mood disorders of late-life
to establish a recruitment referral and collaborative network for elderly bipolar patients in collaboration with the NIMH funded STEP-BD
to establish an outpatient treatment clinic at the Bellefield Towers site of the NIMH funded Intervention Research Center for Late Life Mood Disorders
to implement standardized care pathways compatible with STEP-BD treatment algorithms for mood stabilizing pharmacotherapy
to document short- and long-term treatment response with respect to affective symptoms sleep general life functioning cognition treatment-emergent side effects
to establish the clinical infrastructure necessary for randomized controlled clinical trials and for clinical research training in bipolar mood disorders of late-life
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None